Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2014

View Archived Issues

Phase II results on cediranib in advanced biliary tract cancer

Researchers identify novel polymorphism associated with the risk of miscarriage

Synthetic Biologics and Enterome Bioscience collaborate on microbiome research

FDA grants orphan drug status to Afinitor in DLBCL

Edison Pharmaceuticals obtains FDA orphan drug designation for Leigh syndrome candidate

Isis Pharmaceuticals earns milestone payment for start of phase I ISIS-AR-Rx study

BrainStorm Cell Therapeutics initiates preclinical studies of stem cell therapy in autism

Nymox Pharmaceutical reports new safety study data for NX-1207

Lilly reports topline results from phase III trial of ramucirumab

Amgen presents first-in-human results for AMG-780

High-affinity SV2A PET tracer [11C]UCB-J shows promise in animal models

VGX-100 shows promise as monotherapy or as combination with bevacizumab in first-in-human trial

X-Chem and Pfizer form multi-target collaboration

Beactica enters into drug discovery collaboration with Medivir

AstraZeneca inlicenses Synairgen's SNG-001

University of Pennsylvania researchers gain access to SomaLogic's SOMAscan proteomics platform

Tipelukast shows promise in pulmonary fibrosis model

Genomic Health reports topline results from independent validation study

Chinese company reports discovery of H+/K+-ATPase inhibitors

U.S. investigators patent new compounds for diabetes and obesity

Adelaide Research and Innovation synthesizes novel calpain inhibitors

Northwest Biotherapeutics reports data from phase I/II trial of DCVax-Direct

IRM and Novartis report synthesis of compounds for malaria

Bayer patents detail novel CDK9/CycT1 inhibitors

Phase III data: efficacy of fluticasone furoate/vilanterol improved by adding umeclidinium in COPD

Ruthigen to begin human trials of RUT-58-60 in the U.S.

FDA approves Gadavist as a contrast agent for the evaluation of breast cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...